<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01908569</url>
  </required_header>
  <id_info>
    <org_study_id>IVISEV-004ROVIC</org_study_id>
    <nct_id>NCT01908569</nct_id>
  </id_info>
  <brief_title>Application of MACS and Time-lapse Technology in Good-prognosis Patients</brief_title>
  <official_title>Application of MACS (Magnetic-activated Cell Sorting) and Time-lapse Technology (Embryoscope) in Assisted Reproduction Patients With Good Prognosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Sevilla</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IVI Sevilla</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The MACS technique (magnetic-activated cell sorting) is based on the usage of microbeads,
      magnetic particles with a diameter of 35 nanometers joined to the compound annexin V. Annexin
      V is a protein with a high affinity for the molecule phosphatidylserine. This system allow us
      to eliminate those spermatozoids which have begun the apoptosis and have phosphatidylserine
      residues on their membrane surface. Using this technique, the apoptotic spermatozoids will
      join the microbeads and consequently be retained in a column applying a magnetic field.

      Recent studies show the benefits of spermatozoid selection using MACS and the improvement in
      mobility, viability, DNA fragmentation and fertilization potential. It has also been observed
      an improvement in the embryo cells division rate, clinical pregnancy rates and spermatozoid
      survival after thawing. However, it is necessary to perform new clinical studies in order to
      evaluate the real potential of this technology and its safety.

      The purpose of this study is to evaluate the effect of the MACS technique on the clinical
      results of good-prognosis patients who are going through IVF/ICSI treatments in order to
      achieve a pregnancy.

      The hypothesis of this study is that the application of the MACS technique in assisted
      reproduction treatments is associated with a better embryo quality and pregnancy rates.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>14 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>14 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Embryo quality</measure>
    <time_frame>14 months</time_frame>
    <description>According to ASEBIR criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>14 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>MACS Technique Efficacy</condition>
  <arm_group>
    <arm_group_label>NO MACS + Time-lapse technology</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The sperm capacitation will be performed through a density gradient. This sperm will be used in the IVF/ICSI treatment of the patient and the embryos obtained will be cultured using time-lapse technology (Embryoscope).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MACS + time-lapse technology</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The sperm capacitation will be performed through a density gradient. After that, it will be subjected to the MACS technique in order to select the non-apoptotic spermatozoids. This sperm will be used in the IVF/ICSI treatment of the patient and the embryos obtained will be cultured using time-lapse technology (Embryoscope).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MACS</intervention_name>
    <description>The sperm will be subjected to capacitation through a density gradient together with the MACS technique in order to select the non-apoptotic spermatozoids.</description>
    <arm_group_label>MACS + time-lapse technology</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NO MACS</intervention_name>
    <description>The sperm capacitation will be performed through a density gradient. The MACS technique will not be applied.</description>
    <arm_group_label>NO MACS + Time-lapse technology</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &lt;38 years

          -  &gt;10 follicles with a diameter of ≥10 mm the day before the follicular puncture

        Exclusion Criteria:

          -  Patients subject to preimplantation genetic diagnosis treatments
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victor Blasco, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>IVI Sevilla</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rocío Quiroga, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Sevilla</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cristina González, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>IVI Sevilla</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cinzia Caligara, MD</last_name>
    <role>Study Chair</role>
    <affiliation>IVI Sevilla</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Victor Blasco, MSc</last_name>
    <phone>+34954286274</phone>
    <email>victor.blasco@ivi.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicolás Prados, PhD</last_name>
    <phone>+34954286274</phone>
    <email>nicolas.prados@ivi.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IVI Sevilla</name>
      <address>
        <city>Seville</city>
        <zip>41011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor Blasco, MSc</last_name>
      <phone>+34954286274</phone>
      <email>victor.blasco@ivi.es</email>
    </contact>
    <contact_backup>
      <last_name>Nicolás Prados, PhD</last_name>
      <phone>+34954289274</phone>
      <email>nicolas.prados@ivi.es</email>
    </contact_backup>
    <investigator>
      <last_name>Victor Blasco, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rocío Quiroga, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cinzia Caligara, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina González, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2013</study_first_submitted>
  <study_first_submitted_qc>July 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2013</study_first_posted>
  <last_update_submitted>November 10, 2017</last_update_submitted>
  <last_update_submitted_qc>November 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MACS, time-lapse, embryo, spermatozoid, sperm</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

